{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:03:40Z","timestamp":1789607020783,"version":"build-2803163510"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and purpose<\/jats:title>\n                    <jats:p>Multimodal computed tomography angiography and perfusion (CTA\/CTP) is increasingly used in the emergency department (ED) evaluation of acute ischemic stroke (AIS) but may delay thrombolysis. We examined whether the sequencing of multimodal CTA\/CTP relative to thrombolytic administration affects door-to-needle (DTN) time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of adult patients with AIS treated with intravenous alteplase at a tertiary, academically affiliated ED that is part of a certified Comprehensive Stroke Center between January 1, 2012, and August 1, 2023. All patients underwent an initial noncontrast CT (NCCT), followed by either a contrast-first workflow (i.e. CTA\/CTP) or were given alteplase before proceeding to contrast administration. The primary outcome was DTN time, analyzed using univariate methods and multivariable quantile regression adjusting for stroke severity, pre-alteplase antihypertensive use, thrombectomy (as a correlate for large-vessel occlusion), primary language, and bedside ED pharmacist presence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1,382 AIS encounters, 167 patients met inclusion criteria; 148 underwent CTA\/CTP before alteplase and 19 received alteplase before contrast administration. Median DTN time was significantly shorter in the alteplase-first group (20 minutes [interquartile range (IQR), 15\u201326]) compared with the CTA\/CTP-first group (44 minutes [IQR, 32\u201356]; P&lt;0.001). After adjustment, alteplase-first administration remained independently associated with faster DTN time (\u221225 minutes; 95% CI, \u221234 to \u221216). Higher stroke severity and ED pharmacist presence were also associated with shorter DTN, whereas pre-alteplase antihypertensives, primary language, and thrombectomy were not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A contrast-first strategy incorporating multimodal CTA\/CTP before alteplase administration was associated with approximately twofold longer DTN times. These findings suggest that obtaining CTA\/CTP before thrombolytic administration may substantially prolong DTN times. Larger studies are needed to confirm the magnitude of this association and to identify patient populations most likely to benefit from alternative imaging workflows.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-026-05105-y","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:17:57Z","timestamp":1782800277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of multimodal CT angiography\/perfusion sequencing on alteplase door-to-needle time"],"prefix":"10.1186","volume":"26","author":[{"given":"Zlatan","family":"Coralic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Michaels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Andrew","family":"Josephson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"5105_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000513","author":"S Prabhakaran","year":"2026","unstructured":"Prabhakaran S, Gonzalez NR, Zachrison KS, Adeoye O, Alexandrov AW, Ansari SA, Chapman S, Czap AL, Dumitrascu OM, Ishida K, et al. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association\/American Stroke Association. Stroke. 2026. https:\/\/doi.org\/10.1161\/STR.0000000000000513.","journal-title":"Stroke"},{"key":"5105_CR2","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1016\/S0140-6736(12)60738-7","volume":"379","author":"JM Wardlaw","year":"2012","unstructured":"Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, Cohen G. 5 Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet. 2012;379:2364\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(12)60738-7.","journal-title":"Lancet"},{"key":"5105_CR3","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","volume":"384","author":"J Emberson","year":"2014","unstructured":"Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, et al. 6 Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384:1929\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(14)60584-5.","journal-title":"Lancet"},{"key":"5105_CR4","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1474-4422(16)30076-X","volume":"15","author":"WN Whiteley","year":"2016","unstructured":"Whiteley WN, Emberson J, Lees KR, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, et al. 7 Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis. Lancet Neurol. 2016;15:925\u201333. https:\/\/doi.org\/10.1016\/S1474-4422(16)30076-X.","journal-title":"Lancet Neurol"},{"key":"5105_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/eurpub\/cky066","volume":"28","author":"Y Lachkhem","year":"2018","unstructured":"Lachkhem Y, Rican S, Minvielle E. 11 Understanding delays in acute stroke care: a systematic review of reviews. Eur J Public Health. 2018;28:426\u201333. https:\/\/doi.org\/10.1093\/eurpub\/cky066.","journal-title":"Eur J Public Health"},{"key":"5105_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.nrl.2014.12.004","volume":"31","author":"AM Iglesias Mohedano","year":"2016","unstructured":"Iglesias Mohedano AM, Garcia Pastor A, Garcia Arratibel A, Sobrino Garcia P, Diaz Otero F, Romero Delgado F, Dominguez Rubio R, Munoz Gonzalez A, Vazquez Alen P, Fernandez Bullido Y, et al. Factors associated with in-hospital delays in treating acute stroke with intravenous thrombolysis in a tertiary centre. Neurologia. 2016;31:452\u20138. https:\/\/doi.org\/10.1016\/j.nrl.2014.12.004.","journal-title":"Neurologia"},{"key":"5105_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/acem.12914","volume":"23","author":"PM Choi","year":"2016","unstructured":"Choi PM, Desai JA, Kashyap D, Stephenson C, Kamal N, Vogt S, Bohm V, Suddes M, Bugbee E, Hill MD, et al. 13 Are All Stroke Patients Eligible for Fast Alteplase Treatment? An Analysis of Unavoidable Delays. Acad Emerg Med. 2016;23:393\u20139. https:\/\/doi.org\/10.1111\/acem.12914.","journal-title":"Acad Emerg Med"},{"key":"5105_CR8","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/STROKEAHA.116.015712","volume":"48","author":"N Kamal","year":"2017","unstructured":"Kamal N, Sheng S, Xian Y, Matsouaka R, Hill MD, Bhatt DL, Saver JL, Reeves MJ, Fonarow GC, Schwamm LH, et al. 14 Delays in Door-to-Needle Times and Their Impact on Treatment Time and Outcomes in Get With The Guidelines-Stroke. Stroke. 2017;48:946\u201354. https:\/\/doi.org\/10.1161\/STROKEAHA.116.015712.","journal-title":"Stroke"},{"key":"5105_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1212\/WNL.0b013e31825d6011","volume":"79","author":"A Meretoja","year":"2012","unstructured":"Meretoja A, Strbian D, Mustanoja S, Tatlisumak T, Lindsberg PJ, Kaste M. 15 Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology. 2012;79:306\u201313. https:\/\/doi.org\/10.1212\/WNL.0b013e31825d6011.","journal-title":"Neurology"},{"key":"5105_CR10","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1161\/01.str.0000015625.87603.a7","volume":"33","author":"BC Meyer","year":"2002","unstructured":"Meyer BC, Hemmen TM, Jackson CM, Lyden PD. Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: prospective reliability and validity. Stroke. 2002;33:1261\u20136. https:\/\/doi.org\/10.1161\/01.str.0000015625.87603.a7.","journal-title":"Stroke"},{"key":"5105_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2018.01.056","author":"SR Morgan","year":"2018","unstructured":"Morgan SR, Acquisto NM, Coralic Z, Basalyga V, Campbell M, Kelly JJ, Langkiet K, Pearson C, Sokn E, Phelan M. Clinical pharmacy services in the emergency department. Am J Emerg Med. 2018. https:\/\/doi.org\/10.1016\/j.ajem.2018.01.056.","journal-title":"Am J Emerg Med"},{"key":"5105_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ajem.2025.08.014","volume":"98","author":"KJ Mercer","year":"2025","unstructured":"Mercer KJ, Howington GT, Brown CS, Gilbert BW, Cole K, Acquisto NM, Zimmerman DE, Ray L, Gerberi D, Mattson AE, et al. Assessing the impact of emergency medicine pharmacists on fibrinolytic door-to-needle times in acute ischemic stroke: A systematic review and meta-analysis (Pharmacist-assisted Stroke Treatments I (PhAST-1)). Am J Emerg Med. 2025;98:57\u201364. https:\/\/doi.org\/10.1016\/j.ajem.2025.08.014.","journal-title":"Am J Emerg Med"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05105-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05105-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05105-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:09:48Z","timestamp":1789603788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-05105-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5105"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-05105-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"1 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the University of California San Francisco Institutional Review Board with a waiver of patient informed consent to participate. (reference # 23-39714). The study adhered to the Declaration of Helsinki in regard to research conducted on humans and human data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"587"}}